Our two T-ALL cases were also characterized by aberrant expression of TLX3. T-ALL patients co-expressing TLX3 and NUP214::ABL1 fusion transcript may belong to a subgroup of poor survival (39). The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.